Investing Profile

Barbara Dalton

VCInvestor
Senior Managing Partner at Pfizer Venture Investments
Photo of Barbara Dalton, Vice President at Pfizer Venture Investments
cb
$100K - $15.0M
$10.0M
8
CompanyStageDateRound SizeTotal Raised
Artios Pharma
Series CJul 2021$150M
Series BAug 2018$83M
$270M
Co-investors: Hakan Goker (M Ventures (Merck)), René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Raphael Wisniewski (Andera Partners)
Complexa
Series CJul 2017$62M
$62M
Co-investors: Ven Raju (Innovation Works), Peter Erin (Innovation Works), Sara Nayeem (Avoro Ventures)
Ixchelsis
Series UnknownDec 2016$12M
$12M
Cydan
Series UnknownApr 2013$16M
$60M
Co-investors: David Mott (Mott Family Capital)
Rhythm Pharmaceuticals
Series BNov 2012$33M
$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Steven St. Peter (T1D Fund)
Ablexis
Series AJun 2010$12M
$12M
Co-investors: Lou Tartaglia (Cure Ventures), Cary Pfeffer (Third Rock Ventures)
Flexion Therapeutics
Series AJan 2010$9M
$62M
Co-investors: Andrew Schwab (5am Ventures), Heath Lukatch (Red Tree Venture Capital)